ITP and Avatrombopag Case

ITP and Avatrombopag Case

Current Status
Not Enrolled
Get Started

Case Author: Dr Brian Harnett

Case Reviewer: Dr Donald Arnold

Learning Objectives:

At the end of this self-assessment module, participants should be able to:

  1. Determine appropriate use of thrombopoietin receptor agonists in the setting of immune thrombocytopenia (ITP) and chronic liver disease.
  2. Determine clinical settings where certain thrombopoietin receptor agonists are more appropriate than others
  3. Outline relevant pharmacodynamics and pharmacokinetics of
  4. Describe the initial management of portal vein thrombosis

Scientific Planning Committee

Dr. Pallavi Ganguli – Resident Physician, Hematology
Danyal Ladha – Resident Physician, Hematology
Dr. Joanne Britto – Clinical Fellow, Malignant Hematology (Lymphoproliferative Disorders)
Dr. Yan Xu – Fellow Physician, Hematology/Thrombosis
Dr. Siraj Mithoowani – Clinical Hematologist at St. Joseph’s Healthcare, Hamilton
Dr. Hassan Sibai – Assistant Professor of Medicine, Faculty of Medicine, University of Toronto and Staff Physician,
Division of Medical Hematology & Oncology, Princess Margaret Cancer Centre

Conflict of Interest: None